Standard Duration for Hepatitis C
Pegasys (peginterferon alfa-2a) treatment duration for chronic hepatitis C depends on genotype and whether ribavirin is co-administered. For genotype 1 or 4, it's typically 48 weeks. Genotypes 2 or 3 usually require 24 weeks.[1]
Duration for Hepatitis B
In chronic hepatitis B, Pegasys is given for 48 weeks in HBeAg-positive patients or those with compensated liver disease. Some extend to 72 weeks for non-responders or decompensated cases.[1]
Factors Influencing Length
Treatment length adjusts based on viral load response at week 12 (e.g., early stopping if no decline). Pediatric doses follow adult guidelines, often 48 weeks for genotype 1. Discontinuation occurs if no response by week 12-24.[1]
How Patients Experience It
Full courses demand weekly subcutaneous injections, with monitoring for side effects like flu-like symptoms or depression, which can lead to early termination in 10-20% of cases.1
[1]: https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/103432s5187lbl.pdf (Pegasys FDA Label)